AN2 Therapeutics, Inc. (ANTX) Financials
ANTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 153.8 million | 14.8 million |
2023-06-30 | 98.9 million | 11.2 million |
2023-03-31 | 91.1 million | 8.6 million |
2022-12-31 | 102.6 million | 7.2 million |
ANTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -11.8 million | 2.2 million |
2023-06-30 | -12.8 million | 1.9 million |
2023-03-31 | -11.6 million | 2.1 million |
2022-12-31 | -7.6 million | 1.5 million |
ANTX Net Income
No data available :(
ANTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 123.8 million | - | - |
2023-06-30 | 95.3 million | - | 13000 |
2023-03-31 | 88.5 million | - | 34000 |
2022-12-31 | 96.1 million | - | 53000 |
ANTX Shares Outstanding
ANTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 14.4 million | 3.8 million | - |
2023-06-30 | - | 13.5 million | 3.1 million | - |
2023-03-31 | - | 12.0 million | 4.1 million | - |
2022-12-31 | - | 8.8 million | 3.7 million | - |
ANTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | 21000 |
2023-03-31 | - | 19000 |
2022-12-31 | - | 20000 |
ANTX
Price: $2.56
52 week price:
Earnings Per Share: -2.80 USD
P/E Ratio: -7.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 47599
Market Capitalization: 90.7 million
Average Dividend Frequency: 3